Life ScienceCompany
FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program Ownership
Who owns FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program?
FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program is owned by Appili Therapeutics. It was acquired on November 21, 2019.
FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program Business Overview
Where is FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program headquartered?
FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program is headquartered in Tokyo, Japan.
What sector is FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program in?
FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program is a life science company.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.